Clinical Trial Results:
A RANDOMIZED, OPEN LABEL, TRIAL OF THE PHARMACOKINETICS OF AZITHROMYCIN IN SERUM, BRONCHIAL WASHINGS AND LUNG TISSUE FOLLOWING A SINGLE DOSE OF NEW FORMULATION AZITHROMYCIN MICROSPHERES (2 GRAM) OR COMMERCIAL AZITHROMYCIN TABLET (500 MG) TO CANCER PATIENTS THAT REQUIRE LUNG RESECTION.
Summary
|
|
EudraCT number |
2004-001497-13 |
Trial protocol |
IT |
Global completion date |
15 Apr 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
14 Dec 2016
|
First version publication date |
14 Dec 2016
|
Other versions |
|
Summary report(s) |
A0661145)_Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.